中国P站

Abstract

Neurocysticercosis is a major cause of acquired epilepsy globally, stemming from infection by the larval stage of Taenia solium.
Diagnosis relies on neuroimaging, serology, and epidemiology. Management includes antiparasitic drugs, anti-inflammatories, anti
convulsants, and occasionally surgery. The disease pathogenesis involves inflammation within the central nervous system, leading to
various neurological symptoms. Control of Taenia solium transmission and understanding host immune responses are critical areas
of focus for therapeutic and preventive strategies.